Connect Biopharma News

Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results From the Global Phase 2b Trial of Rademikibart in Patients With Moderate-to-Severe Asthma

SAN DIEGO, CA and TAICANG, China, May 07, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical

Connect Biopharma May 6 23:00

Sector Update: Health Care Stocks Retreating Late Afternoon

Health care stocks eased in late Wednesday afternoon trading, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each decreasing 0.1%. The iShares Biotechnology ETF (IBB

MT NewswiresApr 17 14:53

Sector Update: Health Care

Health care stocks ease in late Wednesday afternoon trading with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both decreasing 0.1%. The iShares Biotechnology ETF (IBB)

MT NewswiresApr 17 14:32

Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer

Connect Biopharma (CNTB) is terminating its in-license agreement for CBP-174, an antiallergic, with Pfizer (PFE), effective May, to optimize resources and extend its cash runway The company said Tuesd

MT NewswiresApr 17 13:48

Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.

Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 17 05:50

HC Wainwright & Co. : The rating of Conrad Biopharmaceuticals (CNTB.US) was maintained, adjusted from buy to buy rating, and the target price was adjusted from $7.00 to $8.00.

HC Wainwright & Co. : The rating of Conrad Biopharmaceuticals (CNTB.US) was maintained, adjusted from buy to buy rating, and the target price was adjusted from $7.00 to $8.00.

Zhitong FinanceApr 17 05:40

HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8

HC Wainwright & Co. analyst Emily Bodnar maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and raises the price target from $7 to $8.

BenzingaApr 17 05:40

Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB) and Clene (CLNN) with bullish sentiments.

TipRanksApr 17 05:20

Connect Biopharma Triumphs With Rademikibart Trials

TipRanksApr 16 16:27

Connect Biopharma GAAP EPS of -$2.15 Misses by $1.33

Seeking AlphaApr 16 15:31

Connect Biopharma Hldgs FY EPS $(1.08) Up From $(2.15) YoY

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(1.08) per share. This is a 49.77 percent increase over losses of $(2.15) per share from the same period last year.

BenzingaApr 16 15:22

Press Release: Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update -- Reported two positive readouts for rademikibart, the Company's lead asset, from the Global Phase 2b

Dow JonesApr 16 15:05

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

Reported two positive readouts for rademikibart, the Company's lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma and from the China pivotal trial in moderate-to-severe

Connect Biopharma Apr 15 23:00

Buy Rating Reaffirmed for Connect Biopharma Holdings Amid Promising Clinical Trials and Strategic Partnerships

TipRanksApr 10 01:17

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersAesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday's after-market session. The company's market cap stands at $24.9 million. Kineta (NASDAQ:KA) shares rose 8.46% to

BenzingaApr 3 15:31

MMAT, CNTB and HGAS Among Mid-day Movers

Seeking AlphaApr 1 11:57

ADRs End Higher; Connect Biopharma Holdings Climbs 21%

This article was automatically generated by Dow Jones Newswires using technology from Automated Insights. International stocks trading in New York closed higher on Wednesday, as the S&P/BNY Mellon in

Dow JonesMar 27 15:40

Connect Biopharma Initiated at Buy by HC Wainwright & Co.

Connect Biopharma Initiated at Buy by HC Wainwright & Co.

Dow JonesMar 4 06:23

Connect Biopharma Hldgs Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/04/2024 438.46% HC Wainwright & Co. → $7 Initiates Coverage On → Buy 09/13/2023 284.62% Cantor Fitzgera

BenzingaMar 4 06:10

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)

TipRanksMar 4 05:31